Illinois Municipal Retirement Fund Acquires 54,229 Shares of Ralliant Corporation $RAL

Illinois Municipal Retirement Fund raised its holdings in Ralliant Corporation (NYSE:RAL) by 1,156.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 58,919 shares of the company’s stock after buying an additional 54,229 shares during the quarter. Illinois Municipal Retirement Fund owned about 0.05% of Ralliant worth $2,577,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Dodge & Cox purchased a new stake in Ralliant in the second quarter worth $523,571,000. Viking Global Investors LP bought a new position in Ralliant in the 2nd quarter worth $257,200,000. State Street Corp purchased a new stake in shares of Ralliant in the 2nd quarter worth about $213,096,000. Flossbach Von Storch SE lifted its position in shares of Ralliant by 1.7% in the 3rd quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock worth $181,605,000 after purchasing an additional 67,963 shares during the period. Finally, Norges Bank bought a new stake in shares of Ralliant during the 2nd quarter valued at about $108,453,000.

Ralliant News Roundup

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Directors/insiders bought stock this week (Kate Mitchell bought 2,350 shares at ~$42.48; Anelise Angelino Sacks bought ~2,000 shares), a signal often read as confidence in the company and a near‑term support for the share price. InsiderTrades: Kate Mitchell Acquires 2,350 Shares The Motley Fool: Director Scoops Up 2,000 Shares
• Neutral Sentiment: Recent quarterly results beat consensus (EPS and revenue) and the company provided Q1 and FY 2026 guidance — fundamentals remain mixed and will be watched closely but are not a new surprise. MarketBeat: Ralliant Earnings & Guidance
• Negative Sentiment: Multiple law firms have publicly opened or promoted investigations into possible securities‑law violations tied to Ralliant (Kaplan Fox, Kirby McInerney, Kessler Topaz, Block & Leviton and others). Those actions increase litigation and regulatory risk and can pressure the stock as legal costs, disclosures and management distraction unfold. Globe and Mail: Kaplan Fox Alert GlobeNewswire: Kirby McInerney Alert
• Negative Sentiment: Ongoing negative analyst moves, higher short interest and prior material non‑cash impairment/guidance reductions (reported earlier) raise downside risk and intraday volatility — these factors can offset positive insider signals and lead to further selling on adverse updates. Kessler Topaz PR Business Insider: Block & Leviton Alert

Ralliant Trading Up 3.4%

Ralliant stock opened at $44.03 on Monday. Ralliant Corporation has a one year low of $37.27 and a one year high of $57.02. The business’s fifty day moving average is $50.79 and its 200 day moving average is $46.56. The stock has a market capitalization of $4.97 billion and a PE ratio of 22.46. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58.

Ralliant (NYSE:RAL) last posted its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The business’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a $0.05 dividend. The ex-dividend date is Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.5%. Ralliant’s dividend payout ratio (DPR) is currently 10.20%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on RAL. Vertical Research raised shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research note on Friday, February 6th. Weiss Ratings lowered Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research report on Thursday, February 5th. Barclays dropped their price target on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Zacks Research downgraded Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Finally, Citigroup lowered their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a research report on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Ralliant currently has a consensus rating of “Hold” and an average price target of $50.50.

Insider Activity at Ralliant

In other news, Director Kevin E. Bryant purchased 1,250 shares of the stock in a transaction dated Friday, February 6th. The shares were purchased at an average cost of $39.97 per share, with a total value of $49,962.50. Following the acquisition, the director directly owned 4,653 shares of the company’s stock, valued at $185,980.41. This represents a 36.73% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Anelise Angelino Sacks acquired 2,000 shares of the business’s stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average cost of $41.25 per share, with a total value of $82,500.00. Following the acquisition, the director directly owned 5,403 shares of the company’s stock, valued at $222,873.75. This trade represents a 58.77% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders acquired 8,145 shares of company stock worth $332,233.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.